BRTX
BioRestorative Therapies Inc

3,738
Mkt Cap
$4.94M
Volume
3.96M
52W High
$2.10
52W Low
$0.19
PE Ratio
-0.15
BRTX Fundamentals
Price
$0.2284
Prev Close
$0.2314
Open
$0.2191
50D MA
$0.9178
Beta
1.40
Avg. Volume
22,986.10
EPS (Annual)
-$1.16
P/B
0.83
Rev/Employee
$36,454.54
$0.3838
Loading...
Loading...

About

BioRestorative Therapies, Inc. engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company's initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process. BioRestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
11

Frequently Asked Questions

What is Market Cap of BioRestorative Therapies Inc?
What is the 52-week high for BioRestorative Therapies Inc?
What is the 52-week low for BioRestorative Therapies Inc?
What is BioRestorative Therapies Inc stock price today?
What was BioRestorative Therapies Inc stock price yesterday?
What is the PE ratio of BioRestorative Therapies Inc?
What is the Price-to-Book ratio of BioRestorative Therapies Inc?
What is the 50-day moving average of BioRestorative Therapies Inc?
How many employees does BioRestorative Therapies Inc have?

Latest BRTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.